This prospective, controlled, open clinical product surveillance trial will evaluate the performance of posterior zirconia ceramic crowns over 24 months
This prospective, controlled, open clinical product surveillance trial will evaluate the performance of posterior zirconia ceramic crowns over 24 months. A total of 40 indirect full-coverage crowns will be fabricated from zirconia ceramic (IPS e.max® ZirCAD Prime Esthetic, Ivoclar Vivadent, Schaan, Liechtenstein) and cemented with ZirCAD Cement (Ivoclar Vivadent), a resin modified glass ionomer luting cement. Clinical evaluation parameters restorations in terms of fracture resistance, marginal adaptation, shade/color match, and other complications will be assessed at baseline and then 6 months, 1 year, and 2 years postoperatively. Descriptive statistics will be used and survival analysis will be estimated with Kaplan-Meier survival analysis.
Study Type
OBSERVATIONAL
Enrollment
40
Full-coverage crowns will be fabricated from zirconia ceramic discs (IPS e.max® ZirCAD Prime Esthetic, Ivoclar Vivadent, Schaan, Liechtenstein) and cemented with ZirCAD Cement (Ivoclar Vivadent) a resin modified glass ionomer luting cement.
Penn Dental Medicine
Philadelphia, Pennsylvania, United States
Survival analysis
Survival analysis will be estimated using Kaplan-Meier survival analysis. Based on the following variables; restoration loss and FDI criteria (Marginal fit, Shade/Color Match, and Incidence of complications)
Time frame: From day 1 of crown placement to follow-up visits at 6, 12, and 24 months.
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.